Evolent Health, Inc. (EVH) Financial Statements
Evolent Health, Inc. (EVH) reported trailing twelve-month revenue of $2.1B (down 4.5% year on year) and net income of -$505.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $24.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EVHEvolent Health, Inc.Follow EVH — free
—
Price chart with a free account
- Market cap
- 542.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.63 | 0.85 | 0.92 | 0.91 | 1.35 | 1.96 | 2.55 | 1.88 | 2.10 | |
| Gross profit | — | — | — | — | 0.32 | 0.46 | 0.37 | 0.40 | 0.36 | |
| Research & development | 0.02 | 0.02 | 0.02 | 0.02 | — | — | — | — | — | |
| Operating income | -0.05 | -0.31 | -0.26 | -0.04 | 0.00 | -0.07 | -0.04 | -0.41 | -0.43 | |
| Pre-tax income | -0.05 | -0.33 | -0.33 | -0.03 | -0.06 | -0.20 | -0.06 | -0.53 | -0.50 | |
| Income tax | 0.00 | -0.02 | -0.00 | 0.00 | -0.04 | -0.09 | -0.00 | -0.00 | 0.00 | |
| Net income | -0.05 | -0.30 | -0.33 | -0.04 | -0.02 | -0.11 | -0.06 | -0.53 | -0.50 | |
| Diluted EPS ($) | -0.68 | -3.67 | -3.94 | -0.44 | -0.20 | -1.28 | -0.81 | -5.07 | -4.57 | |
| Diluted shares (bn) | — | 0.082 | 0.085 | 0.086 | 0.094 | 0.111 | 0.115 | 0.114 | — |
USD billions · SEC XBRL
Evolent Health, Inc. — questions
- What is Evolent Health, Inc.'s revenue?
- $2.1B over the twelve months to 2026-06-30, down 4.5% year on year, from its 10-Q and 10-K filings.
- What is Evolent Health, Inc.'s net income?
- -$505.0M over the twelve months to 2026-06-30.
- What is Evolent Health, Inc.'s free cash flow?
- $24.3M over the twelve months to 2026-06-30.
- What are Evolent Health, Inc.'s diluted earnings per share?
- $-4.57 over the twelve months to 2026-06-30.
Every figure on this page comes from Evolent Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.